Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

Recruiting now · Phase 2

Conditions studied: Opioid Use, Stimulant Use, Depression and Anxiety Symptoms

In brief

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.

Key facts

Study ID

NCT07673380

Run by

Washington University School of Medicine

People needed

300

Starts

2025-08-31

Expected to finish

2027-02-28

Last updated by the study team

2026-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a history of opioid and/or stimulant use
• Identify as Black and/or African American
• Seek treatment at local substance use treatment centers
• Fluent in English
• U.S. resident
• 18 years of age or older at the time of data collection.

You may not qualify if…

• Self-reported cognitive impairment that would limit ability to participate in research.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.